Viva Biotech Holdings VBIZF
0.19 USD 0.00 (+0.00%)
At closeNov 10, 2026, 4:00 PM EST
0.1913 Day range 0.192
0.1349 52-week range 0.3434
- YTD
- -1.34%
- 1 year
- -27.43%
- Market cap
- 400.50M
- EPS (ttm)
- 0.01
- P/E ratio
- 19.13
- YTD return
- -1.34%
- 1-year return
- -27.43%
- Volume
- 5.50K
- Avg volume
- 95
- Open
- 0.192
- Previous close
- 0.1913
- Day's range
- 0.1913 – 0.192
- 52-week range
- 0.1349 – 0.3434
No chart data for this range yet.
News
Viva Biotech Announces 2025 Annual Results: AI-Driven Drug Discovery Reinforces Industry Leadership, CDMO Commercial Products Enter Rapid Scale-Up 
Viva Biotech Accelerates AI-Driven Drug Discovery and Advance the 'Lab-in-the-Loop' with NVIDIA 
Adventures in DMPK: Viva Biotech's One-Stop Pharmacology Platform Cross New Modalities 
Viva Biotech's invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion. 
Viva Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry 
Unlocking the Potential of Cyclic Peptide Therapeutics: Viva Biotech's Discovery Insights 
Viva Biotech Announces Its 2025 Interim Results: CRO Revenue Returned to Positive Growth, New CDMO Commercialization Projects Showed Promising Growth 
Viva Biotech's Wholly-Owned Subsidiary Langhua Pharmaceutical Successfully Passes U.S. FDA On-Site Inspection 
Viva Biotech Announces 2024 Annual Results: Significantly Rebounding in Performance with New Stage ahead, AI Leads to a New Era of Novel Drug R&D 
Viva Biotech Officially Establishes Boston Branch, Marking Another Milestone in Global Expansion
Your note
Sign in to keep a note on VBIZF — it syncs with the Stock Master app.